The Raleigh, North Carolina region emerges as a key hub in pharma onshoring surge. This and more in this week’s life sciences update. … READ MORE >
FDA
5 things to know in life sciences: Week of March 31, 2025
Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
5 things to know in life sciences: Week of Jan. 13, 2025
J.P. Morgan Healthcare Conference highlights and more in this week’s life sciences update. … READ MORE >
5 things to know in life sciences: Week of Jan. 6, 2025
Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
5 things to know in life sciences: Week of Dec. 16, 2024
Manufacturing takes center stage in biopharma. This and more in this week’s life sciences update. … READ MORE >
5 things to know in life sciences: Week of December 9, 2024
Each week we highlight five things affecting the life sciences industry. Here’s the latest. FTC appointments possibly signal decreased scrutiny on biopharma M&A President-elect Donald Trump’s nomination of Andrew Ferguson and Mark Meador to the Federal Trade Commission signals a potential shift toward a more business-friendly antitrust approach, focusing on … … READ MORE >
5 things to know in life sciences: Week of December 2, 2024
Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
5 things to know in life sciences: Week of November 18, 2024
Each week we highlight five things affecting the life sciences industry. Here’s the latest. CAR-T therapy for lupus gains attention CAR-T cell therapy shows significant potential in treating lupus—as discussed at ACR 2024–with early trials indicating improved patient outcomes and reduced disease activity, reports BioSpace. Researchers are optimistic about expanding … … READ MORE >
5 things to know in life sciences: Week of November 4, 2024
Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
Medtech executives discuss regulatory collaboration, AI, strategic funding and more
What’s on the minds of the world’s top medtech executives? … READ MORE >